Home Markets Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

Dec 21, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/lillys-weightloss-drug-zepbound-wins-us-fda-approval-for-sleep-apnea-3785420

You May Also Like

Google’s fiber business to merge with Astound Broadband

Joby Aviation’s first production model electric air taxi takes off

Morgan Stanley caps redemptions at private credit fund as withdrawals spike

UK watchdogs press Meta, TikTok, Snap and YouTube to block children

AI coding startup Cursor in talks for funding at $50 bln valuation- Bloomberg

Wall St futures slip as oil extends surge on Strait of Hormuz attacks